Yidu Tech's Two Data Intelligence Products Receive National 'Independent and Original Product Certification' from China Information Technology Security Evaluation Center

Recently, the “Core Module of Intelligent Medical Data Platform (Version 2.7.0)” and the “Core Module of Intelligent Research Platform for Specific Diseases (Version 8.0.0)” (i.e., the Specific Disease Database), developed by Yidu Cloud under Yidu Tech (2158.HK), have passed the evaluation conducted by the China Information Technology Security Evaluation Center and obtained the Certificate for Self-Developed Original Products, becoming the first healthcare technology product to receive this certification.

Independent and original product evaluation is a significant measure encouraged by the state to promote indigenous innovation and protect intellectual property rights. The China Information Technology Security Evaluation Center (CNITSEC) conducts evaluations of information technology products under national authorization, and its evaluation reports are nationally authoritative, objective, and standardized. The evaluation concluded that Yidu Cloud’s two approved data intelligence products feature clear functional architectures, are well-maintained, and have passed source code homology analysis testing. The evaluation also affirmed the company’s independent research and development capabilities and environment.

Medical AI is a technology-intensive industry, and continuous R&D serves as the cornerstone of corporate development. Yan Jun, Chief Technology Officer and Chief AI Scientist at Yidu Cloud, stated, “Receiving this certification signifies national recognition and affirmation of Yidu Cloud’s years-long commitment to independent originality and technological innovation, and it serves as the greatest encouragement for our continued growth. Bearing our responsibilities to the industry, Yidu Cloud will continue to strengthen its technical R&D capabilities, ensuring that value-oriented precision medicine benefits everyone.”

Over the past eight years since its inception, the company has remained committed to continuous R&D, addressing critical industry pain points. With over RMB 1 billion invested in research and development in the last five years, it has deeply explored the application of natural language understanding, knowledge graphs, and privacy-preserving computation in healthcare scenarios. This has strengthened its core capabilities in medical big data processing, model building, and value extraction, thereby promoting the interdisciplinary integration of medicine and AI. To date, the company has provided solutions and services to more than 600 hospitals across over 20 provinces in China and to more than 120 pharmaceutical companies, offering robust technical support for epidemic prevention and control in over a dozen cities.

Enterprises constitute one of the micro-foundations for China to achieve its goal of “joining the forefront of innovative nations.” The purpose of independent research and development is not only to promote high-quality industrial development but also to meet the needs of the country and its people. Adhering to public welfare orientation and market demand, Yidu Cloud strives to transform technology into tangible products, refining every detail to create product experiences that exceed user expectations. The two products recently certified—the Intelligent Medical Data Platform and the Disease-Specific Database—are typical examples. Currently, Yidu Cloud’s products cover 60 disease areas, including more than 20 major cancer types, and have contributed to over 120 high-quality academic papers. Furthermore, in collaboration with experts, the company has published more than ten standardized disease datasets, laying the foundation for multi-center studies.

In the future, Yidu Cloud will continuously iterate and upgrade its technological product ecosystem through practical application, assisting in resolving issues related to data interoperability, data governance, and data utilization. By helping researchers enhance the efficiency of generating real-world evidence, deepening the understanding of disease etiology, progression, diagnosis, treatment, and management, and accelerating the production of high-quality outcomes, Yidu Cloud aims to maximize patient benefits.